Literature DB >> 16883602

Biglycan binds to alpha- and gamma-sarcoglycan and regulates their expression during development.

Michael S Rafii1, Hiroki Hagiwara, Mary Lynn Mercado, Neung S Seo, Tianshun Xu, Tracey Dugan, Rick T Owens, Magnus Hook, David J McQuillan, Marian F Young, Justin R Fallon.   

Abstract

The dystrophin-associated protein complex (DAPC), which links the cytoskeleton to the extracellular matrix, is essential for muscle cell survival, and is defective in a wide range of muscular dystrophies. The DAPC contains two transmembrane subcomplexes-the dystroglycans and the sarcoglycans. Although several extracellular binding partners have been identified for the dystroglycans, none have been described for the sarcoglycan subcomplex. Here we show that the small leucine-rich repeat (LRR) proteoglycan biglycan binds to alpha- and gamma-sarcoglycan as judged by ligand blot overlay and co-immunoprecipitation assays. Our studies with biglycan-decorin chimeras show that alpha- and gamma-sarcoglycan bind to distinct sites on the polypeptide core of biglycan. Both biglycan proteoglycan as well as biglycan polypeptide lacking glycosaminoglycan (GAG) side chains are components of the dystrophin glycoprotein complex isolated from adult skeletal muscle membranes. Finally, our immunohistochemical and biochemical studies with biglycan null mice show that the expression of alpha- and gamma-sarcoglycan is selectively reduced in muscle from young (P14-P21) animals, while levels in adult muscle (> or = P35) are unchanged. We conclude that biglycan is a ligand for two members of the sarcoglycan complex and regulates their expression at discrete developmental ages. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16883602      PMCID: PMC2929672          DOI: 10.1002/jcp.20740

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  57 in total

1.  Transient up-regulation of biglycan during skeletal muscle regeneration: delayed fiber growth along with decorin increase in biglycan-deficient mice.

Authors:  Juan Carlos Casar; Beth A McKechnie; Justin R Fallon; Marian F Young; Enrique Brandan
Journal:  Dev Biol       Date:  2004-04-15       Impact factor: 3.582

2.  Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.

Authors:  T R Fuerst; E G Niles; F W Studier; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

3.  Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension.

Authors:  R M Horton; H D Hunt; S N Ho; J K Pullen; L R Pease
Journal:  Gene       Date:  1989-04-15       Impact factor: 3.688

4.  Site-directed mutagenesis by overlap extension using the polymerase chain reaction.

Authors:  S N Ho; H D Hunt; R M Horton; J K Pullen; L R Pease
Journal:  Gene       Date:  1989-04-15       Impact factor: 3.688

5.  Dystrophin: the protein product of the Duchenne muscular dystrophy locus.

Authors:  E P Hoffman; R H Brown; L M Kunkel
Journal:  Cell       Date:  1987-12-24       Impact factor: 41.582

6.  Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues.

Authors:  P Bianco; L W Fisher; M F Young; J D Termine; P G Robey
Journal:  J Histochem Cytochem       Date:  1990-11       Impact factor: 2.479

7.  Decorin, a chondroitin/dermatan sulfate proteoglycan is under neural control in rat skeletal muscle.

Authors:  E Brandan; M E Fuentes; W Andrade
Journal:  J Neurosci Res       Date:  1992-05       Impact factor: 4.164

8.  Cap-independent translation of mRNA conferred by encephalomyocarditis virus 5' sequence improves the performance of the vaccinia virus/bacteriophage T7 hybrid expression system.

Authors:  O Elroy-Stein; T R Fuerst; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

9.  Biglycan and decorin induce morphological and cytoskeletal changes involving signalling by the small GTPases RhoA and Rac1 resulting in lung fibroblast migration.

Authors:  Ellen Tufvesson; Gunilla Westergren-Thorsson
Journal:  J Cell Sci       Date:  2003-12-01       Impact factor: 5.285

10.  Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species.

Authors:  L W Fisher; J D Termine; M F Young
Journal:  J Biol Chem       Date:  1989-03-15       Impact factor: 5.157

View more
  22 in total

1.  Biglycan recruits utrophin to the sarcolemma and counters dystrophic pathology in mdx mice.

Authors:  Alison R Amenta; Atilgan Yilmaz; Sasha Bogdanovich; Beth A McKechnie; Mehrdad Abedi; Tejvir S Khurana; Justin R Fallon
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

2.  Potential roles for the small leucine-rich proteoglycans biglycan and fibromodulin in ectopic ossification of tendon induced by exercise and in modulating rotarod performance.

Authors:  T Kilts; L Ameye; F Syed-Picard; M Ono; A D Berendsen; A Oldberg; A-M Heegaard; Y Bi; M F Young
Journal:  Scand J Med Sci Sports       Date:  2009-04-13       Impact factor: 4.221

Review 3.  Approaching a new age in Duchenne muscular dystrophy treatment.

Authors:  Kathryn R Wagner
Journal:  Neurotherapeutics       Date:  2008-10       Impact factor: 7.620

Review 4.  The collagen VI-related myopathies Ullrich congenital muscular dystrophy and Bethlem myopathy.

Authors:  Carsten G Bönnemann
Journal:  Handb Clin Neurol       Date:  2011

5.  Androgen regulated genes in human prostate xenografts in mice: relation to BPH and prostate cancer.

Authors:  Harold D Love; S Erin Booton; Braden E Boone; Joan P Breyer; Tatsuki Koyama; Monica P Revelo; Scott B Shappell; Jeffrey R Smith; Simon W Hayward
Journal:  PLoS One       Date:  2009-12-21       Impact factor: 3.240

Review 6.  Transverse tubule remodelling: a cellular pathology driven by both sides of the plasmalemma?

Authors:  David J Crossman; Isuru D Jayasinghe; Christian Soeller
Journal:  Biophys Rev       Date:  2017-07-10

7.  LDL particle core enrichment in cholesteryl oleate increases proteoglycan binding and promotes atherosclerosis.

Authors:  John T Melchior; Janet K Sawyer; Kathryn L Kelley; Ramesh Shah; Martha D Wilson; Roy R Hantgan; Lawrence L Rudel
Journal:  J Lipid Res       Date:  2013-06-26       Impact factor: 5.922

8.  Biglycan is an extracellular MuSK binding protein important for synapse stability.

Authors:  Alison R Amenta; Hilliary E Creely; Mary Lynn T Mercado; Hiroki Hagiwara; Beth A McKechnie; Beatrice E Lechner; Susana G Rossi; Qiang Wang; Rick T Owens; Emilio Marrero; Lin Mei; Werner Hoch; Marian F Young; David J McQuillan; Richard L Rotundo; Justin R Fallon
Journal:  J Neurosci       Date:  2012-02-15       Impact factor: 6.167

Review 9.  Soluble biglycan as a biomarker of inflammatory renal diseases.

Authors:  Louise Tzung-Harn Hsieh; Madalina-Viviana Nastase; Jinyang Zeng-Brouwers; Renato V Iozzo; Liliana Schaefer
Journal:  Int J Biochem Cell Biol       Date:  2014-08-01       Impact factor: 5.085

10.  De novo expression of circulating biglycan evokes an innate inflammatory tissue response via MyD88/TRIF pathways.

Authors:  Jinyang Zeng-Brouwers; Janet Beckmann; Madalina-Viviana Nastase; Renato V Iozzo; Liliana Schaefer
Journal:  Matrix Biol       Date:  2013-12-18       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.